4//SEC Filing
Woolson Daniel 4
Accession 0001698998-24-000003
CIK 0000883984other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:49 PM ET
Size
8.7 KB
Accession
0001698998-24-000003
Insider Transaction Report
Form 4
Woolson Daniel
VP, GM-Infusion Capital
Transactions
- Exercise/Conversion
Common Stock
2024-03-15+2,923→ 16,903 total - Tax Payment
Common Stock
2024-03-15$98.08/sh−1,294$126,916→ 15,609 total - Exercise/Conversion
Performance Shares
2024-03-15−2,923→ 5,847 totalExercise: $0.00Exp: 2026-03-15→ Common Stock (2,923 underlying)
Footnotes (3)
- [F1]These Securities are Performance-based Restricted Stock Units (PRSU).
- [F2]There is neither a purchase price nor an exercise price for the PRSUs.
- [F3]One-third of the shares shall vest on each of the first, second, and third anniversaries of the grant date. The vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and thirty percent of the exercise price per share for thirty consecutive trading days. The appreciation must occur within four years from the grant date.
Documents
Issuer
ICU MEDICAL INC/DE
CIK 0000883984
Entity typeother
Related Parties
1- filerCIK 0001698998
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:49 PM ET
- Size
- 8.7 KB